Manchester Capital Management LLC raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 40,610.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,735 shares of the biotechnology company’s stock after purchasing an additional 7,716 shares during the period. Manchester Capital Management LLC’s holdings in Axon Enterprise were worth $3,268,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the company. Rockefeller Capital Management L.P. boosted its holdings in Axon Enterprise by 53.2% during the fourth quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock valued at $6,542,000 after acquiring an additional 4,002 shares during the period. MassMutual Private Wealth & Trust FSB grew its position in shares of Axon Enterprise by 122,993.6% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 461,601 shares of the biotechnology company’s stock valued at $195,036,000 after purchasing an additional 461,226 shares during the last quarter. B. Metzler seel. Sohn & Co. AG acquired a new stake in shares of Axon Enterprise in the second quarter valued at about $3,854,000. Arrowstreet Capital Limited Partnership bought a new position in shares of Axon Enterprise in the first quarter worth about $15,067,000. Finally, Brown Lisle Cummings Inc. increased its stake in shares of Axon Enterprise by 97,231.4% in the second quarter. Brown Lisle Cummings Inc. now owns 34,066 shares of the biotechnology company’s stock worth $19,098,000 after purchasing an additional 34,031 shares during the period. Institutional investors own 79.08% of the company’s stock.
Insider Activity at Axon Enterprise
In related news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the transaction, the insider owned 97,761 shares in the company, valued at $61,266,818.70. This represents a 8.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 47,397 shares of company stock worth $26,722,984 over the last ninety days. Corporate insiders own 4.20% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on AXON. Piper Sandler cut their price objective on Axon Enterprise from $732.00 to $561.00 and set an “overweight” rating for the company in a research report on Tuesday. Argus raised their target price on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a report on Wednesday, August 5th. Raymond James Financial set a $675.00 price target on Axon Enterprise in a research report on Thursday, October 15th. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, September 2nd. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $689.94.
Read Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Price Performance
Shares of Axon Enterprise stock opened at $420.37 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $764.02. The firm has a fifty day moving average price of $480.64 and a two-hundred day moving average price of $473.90. The company has a market cap of $34.15 billion, a PE ratio of 174.43, a price-to-earnings-growth ratio of 7.88 and a beta of 1.44.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same period last year, the business posted $2.12 EPS. The business’s quarterly revenue was up 35.3% on a year-over-year basis. Analysts expect that Axon Enterprise, Inc will post 2.10 EPS for the current year.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.
Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.
The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
- Chefs’ Warehouse Has Rallied 76%—Can the Stock Keep Climbing?
- MarketBeat Week in Review – 10/19 – 10/23
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
